FeesSafety
Pluang+

FDA accepts sNDA for selinexor plus ruxolitinib in myelofibrosis, decision due June 28, 2027

Market News
17 Nov 2026, 14:30 WIB
PRNewsWire
View Source
Bullish
FDA accepts sNDA for selinexor plus ruxolitinib in myelofibrosis, decision due June 28, 2027

Karyopharm Therapeutics announced the FDA has accepted its supplemental New Drug Application for XPOVIO (selinexor) combined with ruxolitinib to treat myelofibrosis, with a target decision date of June 28, 2027. This combination could become the first approved therapy for myelofibrosis patients, addressing a significant unmet need beyond current JAK inhibitors. The application is based on positive Phase 3 SENTRY trial results showing efficacy in spleen volume reduction and symptom improvement. If approved, Karyopharm plans to launch the treatment promptly to benefit patients with this rare blood cancer.

Karyopharm's XPOVIO and ruxolitinib combination is under FDA review for myelofibrosis treatment. For readers following the health sector, here is Pluang's market snapshot as of Nov 17, 2026 18:51 WIB: Out of 150 priced US health stocks, 51 rose and 91 fell. Notable movers include DYN at USD 16.35 (-2.10%), GH at USD 146.98 (+2.05%), and MDLN at USD 38.44 (-1.86%).

More News

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
58 minutes ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
58 minutes ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
58 minutes ago
Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan, with over 25 years in financial technology including roles at Goldman Sachs and Coinbase, has joined Dune as Director of Engineering. He will lead the engineering efforts behind Dune Market Data Feeds, which provide real-time trade and liq...

Others
Bullish
58 minutes ago
BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock, Inc. has increased its total voting rights in ICG PLC to 5.16% as of November 13, 2026, up from 5.17% previously reported. This includes 5.08% voting rights attached to shares and 0.08% through financial instruments. The notification was o...

Market News
Neutral
58 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App